Available studies (145 found)
Short citation | Full citation | Bioassay | Epidemiology | Epi. meta-analysis | In vitro | Ecology |
---|---|---|---|---|---|---|
Singh 2012 (iv) | Singh TS, Lee S, Kim HH, Choi JK, and Kim SH. 2012. Perfluorooctanoic acid induces mast cell-mediated allergic inflammation by the release of histamine and inflammatory mediators. Toxicol Lett 210(1): 64-70. | |||||
Sletten 2016 | Sletten S et al. Organohalogenated contaminants in white-tailed eagle (Haliaeetus albicilla) nestlings: An assessment of relationships to immunoglobulin levels, telomeres and oxidative stress. Sci. Total Environ. 2016; 539 ():337-49. PubMed DOI | |||||
Smit 2015 | Smit LA et al. Prenatal exposure to environmental chemical contaminants and asthma and eczema in school-age children. Allergy 2015; 70 (6):653-60. PubMed DOI | |||||
Smits and Nain 2013 | Smits JE, and Nain S. 2013. Immunomodulation and hormonal disruption without compromised disease resistance in perfluorooctanoic acid (PFOA) exposed Japanese quail. Environ Pollut 179: 13-18. PubMed DOI | |||||
Son 2009 | Son HY, Lee S, Tak EN, Cho HS, Shin HI, Kim SH, and Yang JH. 2009. Perfluorooctanoic acid alters T lymphocyte phenotypes and cytokine expression in mice. Environ Toxicol 24(6): 580-588. PubMed DOI | |||||
Steenland 2013 | Steenland K, Zhao L, Winquist A, and Parks C. 2013. Ulcerative Colitis and Perfluorooctanoic Acid (PFOA) in a Highly Exposed Population of Community Residents and Workers in the Mid-Ohio Valley. Environ Health Perspect. PubMed DOI | |||||
Steenland 2015 | Steenland K, Zhao L, and Winquist A. 2015. A cohort incidence study of workers exposed to perfluorooctanoic acid (PFOA). Occupational Environmental Medicine 0: 1-8. PubMed DOI | |||||
Stein 2015 | Stein CR, McGovern KJ, Pajak AM, Maglione PJ, Wolff MS. Perfluoroalkyl and polyfluoroalkyl substances and indicators of immune function in children aged 12-19 y: National Health and Nutrition Examination Survey. Pediatr. Res. 2015; (in press):None. PubMed DOI | |||||
Tan 2013 | Tan X, Xie G, Sun X, Li Q, Zhong W, Qiao P, Sun X, Jia W, and Zhou Z. 2013. High fat diet feeding exaggerates perfluorooctanoic acid-induced liver injury in mice via modulating multiple metabolic pathways. PLoS ONE 8(4): e61409. PubMed DOI | |||||
Taylor 2002 | Taylor BK, Dadia N, Yang CB, Krishnan S, and Badr M. 2002. Peroxisome proliferator-activated receptor agonists inhibit inflammatory edema and hyperalgesia. Inflammation 26(3): 121-127. PubMed | |||||
Taylor 2005 | Taylor BK, Kriedt C, Nagalingam S, Dadia N, and Badr M. 2005. Central administration of perfluorooctanoic acid inhibits cutaneous inflammation. Inflamm Res 54(6): 235-242. PubMed | |||||
Uhl 2013 | Uhl SA, James-Todd T, and Bell ML. 2013. Association of Osteoarthritis with Perfluorooctanoate and Perfluorooctane Sulfonate in NHANES 2003-2008. Environ Health Perspect 121(4): 447-452, 452e441-443. PubMed DOI | |||||
Vetvicka 2013 | Vetvicka V, and Vetvickova J. 2013. Reversal of perfluorooctanesulfonate-induced immunotoxicity by a glucan-resveratrol-vitamin C combination. Oriental Pharmacy and Experimental Medicine 13(1): 77-84. | |||||
Wan 2006 | Wan YJ, and Badr MZ. 2006. Inhibition of Carrageenan-Induced Cutaneous Inflammation by PPAR Agonists Is Dependent on Hepatocyte-Specific Retinoid X ReceptorAlpha. PPAR Res 2006: 96341. PubMed | |||||
Wang 2011a | Wang IJ, Hsieh WS, Chen CY, Fletcher T, Lien GW, Chiang HL, Chiang CF, Wu TN, and Chen PC. 2011. The effect of prenatal perfluorinated chemicals exposures on pediatric atopy. Environ Res 111(6): 785-791. PubMed DOI | |||||
Wang 2011b | Wang Y, Wang L, Liang Y, Qiu W, Zhang J, Zhou Q, and Jiang G. 2011. Modulation of dietary fat on the toxicological effects in thymus and spleen in BALB/c mice exposed to perfluorooctane sulfonate. Toxicol Lett 204(2-3): 174-182. PubMed DOI | |||||
Wang 2014 | Wang Y, Wang L, Li J, Liang Y, Ji H, Zhang J, Zhou Q, and Jiang G. 2014. The mechanism of immunosuppression by perfluorooctanoic acid in BALB/c mice. Toxicology Research 3(3): 205-213. | |||||
Wang 2015 | Wang C, Nie X, Zhang Y, Li T, Mao J, Liu X, Gu Y, Shi J, Xiao J, Wan C, Wu Q. 2015. Reactive oxygen species mediate nitric oxide production through ERK/JNK MAPK signaling in HAPI microglia after PFOS exposure. Toxicol Appl Pharmacol 288(2): 143-151. PubMed DOI | |||||
Watanabe 2010 | Watanabe MX, Kunisue T, Tao L, Kannan K, Subramanian A, Tanabe S, and Iwata H. 2010. Dioxin-like and perfluorinated compounds in pigs in an Indian open waste dumping site: toxicokinetics and effects on hepatic cytochrome P450 and blood plasma hormones. Environ Toxicol Chem 29(7): 1551-1560. PubMed DOI | |||||
Weber 2014 | Weber K, Fischl AF, Murray PJ, and Conway B. 2014. The effect of BMI on cardiovascular and metabolic syndrome risk factors in an appalachian pediatric population. Circulation 129. PubMed DOI | |||||
Wei 2008 | Wei Y, Liu Y, Wang J, Tao Y, and Dai J. 2008. Toxicogenomic analysis of the hepatic effects of perfluorooctanoic acid on rare minnows (Gobiocypris rarus). Toxicol Appl Pharmacol 226(3): 285-297. PubMed | |||||
Wei 2009 | Wei Y, Shi X, Zhang H, Wang J, Zhou B, and Dai J. 2009. Combined effects of polyfluorinated and perfluorinated compounds on primary cultured hepatocytes from rare minnow (Gobiocypris rarus) using toxicogenomic analysis. Aquat Toxicol 95(1): 27-36. PubMed DOI | |||||
Wens 2013 | Wens B, De Boever P, Verbeke M, Hollanders K, and Schoeters G. 2013. Cultured human peripheral blood mononuclear cells alter their gene expression when challenged with endocrine-disrupting chemicals. Toxicology 303: 17-24. PubMed DOI | |||||
White 2011 | White SS, Fenton SE, and Hines EP. 2011. Endocrine disrupting properties of perfluorooctanoic acid. J Steroid Biochem Mol Biol 127(1-2): 16-26. PubMed DOI | |||||
Wirth 2014 | Wirth JR, Peden-Adams MM, White ND, Bossart GD, and Fair PA. 2014. In vitro PFOS exposure on immune endpoints in bottlenose dolphins (Tursiops truncatus) and mice. J Appl Toxicol 34(6): 658-666. PubMed DOI |
Showing studies 101-125 of 145